Works matching AU Ferrari, Silvia Martina


Results: 91
    1

    Cytokines as Targets of Novel Therapies for Graves' Ophthalmopathy.

    Published in:
    Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2021.654473
    By:
    • Fallahi, Poupak;
    • Ferrari, Silvia Martina;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Paparo, Sabrina Rosaria;
    • Patrizio, Armando;
    • Camastra, Stefania;
    • Miccoli, Mario;
    • Cavallini, Gabriella;
    • Benvenga, Salvatore;
    • Antonelli, Alessandro
    Publication type:
    Article
    2
    3

    L-T4 Therapy in Enteric Malabsorptive Disorders.

    Published in:
    Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2021.626371
    By:
    • Fallahi, Poupak;
    • Ferrari, Silvia Martina;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Paparo, Sabrina Rosaria;
    • Antonelli, Alessandro
    Publication type:
    Article
    4

    Monokine Induced by Interferon γ (IFNγ) (CXCL9) and IFNγ Inducible T-Cell α-Chemoattractant (CXCL11) Involvement in Graves’ Disease and Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 5, p. 1803, doi. 10.1210/jc.2008-2450
    By:
    • Antonelli, Alessandro;
    • Ferrari, Silvia Martina;
    • Fallahi, Poupak;
    • Frascerra, Silvia;
    • Santini, Eleonora;
    • Franceschini, Stefano Sellari;
    • Ferrannini, Ele
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Selective use of vandetanib in the treatment of thyroid cancer.

    Published in:
    Drug Design, Development & Therapy, 2015, v. 9, p. 3459, doi. 10.2147/DDDT.S72495
    By:
    • Fallahi, Poupak;
    • Di Bari, Flavia;
    • Ferrari, Silvia Martina;
    • Spisni, Roberto;
    • Materazzi, Gabriele;
    • Miccoli, Paolo;
    • Benvenga, Salvatore;
    • Antonelli, Alessandro
    Publication type:
    Article
    15

    Selective use of vandetanib in the treatment of thyroid cancer.

    Published in:
    Drug Design, Development & Therapy, 2015, v. 9, p. 3459, doi. 10.2147/DDDT.S72495
    By:
    • Fallahi, Poupak;
    • Di Bari, Flavia;
    • Ferrari, Silvia Martina;
    • Spisni, Roberto;
    • Materazzi, Gabriele;
    • Miccoli, Paolo;
    • Benvenga, Salvatore;
    • Antonelli, Alessandro
    Publication type:
    Article
    16

    Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer.

    Published in:
    Expert Opinion on Pharmacotherapy, 2024, v. 25, n. 12, p. 1667, doi. 10.1080/14656566.2024.2393281
    By:
    • Ferrari, Silvia Martina;
    • Patrizio, Armando;
    • Stoppini, Giulio;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Balestri, Eugenia;
    • Botrini, Chiara;
    • Rugani, Licia;
    • Barozzi, Emilio;
    • Mazzi, Valeria;
    • La Motta, Concettina;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    17
    18
    19

    Myoinositol in Autoimmune Thyroiditis.

    Published in:
    Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.930756
    By:
    • Paparo, Sabrina Rosaria;
    • Ferrari, Silvia Martina;
    • Patrizio, Armando;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Botrini, Chiara;
    • Balestri, Eugenia;
    • Guarneri, Fabrizio;
    • Benvenga, Salvatore;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    20
    21
    22

    Sorafenib in the treatment of thyroid cancer.

    Published in:
    Expert Review of Anticancer Therapy, 2015, v. 15, n. 8, p. 863, doi. 10.1586/14737140.2015.1064770
    By:
    • Ferrari, Silvia Martina;
    • Politti, Ugo;
    • Spisni, Roberto;
    • Materazzi, Gabriele;
    • Baldini, Enke;
    • Ulisse, Salvatore;
    • Miccoli, Paolo;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    23
    24

    Cytokines and HCV-Related Disorders.

    Published in:
    Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/468107
    By:
    • Fallahi, Poupak;
    • Ferri, Clodoveo;
    • Ferrari, Silvia Martina;
    • Corrado, Alda;
    • Sansonno, Domenico;
    • Antonelli, Alessandro
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    Teprotumumab for the treatment of thyroid eye disease.

    Published in:
    Expert Opinion on Biological Therapy, 2023, v. 23, n. 2, p. 123, doi. 10.1080/14712598.2023.2172328
    By:
    • Fallahi, Poupak;
    • Ragusa, Francesca;
    • Paparo, Sabrina Rosaria;
    • Elia, Giusy;
    • Balestri, Eugenia;
    • Mazzi, Valeria;
    • Patrizio, Armando;
    • Botrini, Chiara;
    • Benvenga, Salvatore;
    • Ferrari, Silvia Martina;
    • Antonelli, Alessandro
    Publication type:
    Article
    31
    32
    33

    Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism.

    Published in:
    Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.750380
    By:
    • Ferrari, Silvia Martina;
    • Ragusa, Francesca;
    • Elia, Giusy;
    • Paparo, Sabrina Rosaria;
    • Mazzi, Valeria;
    • Baldini, Enke;
    • Benvenga, Salvatore;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    34

    Precision Medicine in Graves' Disease and Ophthalmopathy.

    Published in:
    Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.754386
    By:
    • Elia, Giusy;
    • Fallahi, Poupak;
    • Ragusa, Francesca;
    • Paparo, Sabrina Rosaria;
    • Mazzi, Valeria;
    • Benvenga, Salvatore;
    • Antonelli, Alessandro;
    • Ferrari, Silvia Martina
    Publication type:
    Article
    35

    Sorafenib and Thyroid Cancer.

    Published in:
    BioDrugs, 2013, v. 27, n. 6, p. 615, doi. 10.1007/s40259-013-0049-y
    By:
    • Fallahi, Poupak;
    • Ferrari, Silvia Martina;
    • Santini, Francesca;
    • Corrado, Alda;
    • Materazzi, Gabriele;
    • Ulisse, Salvatore;
    • Miccoli, Paolo;
    • Antonelli, Alessandro
    Publication type:
    Article
    36
    37
    38

    Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo.

    Published in:
    Oncology Reports, 2018, v. 39, n. 5, p. 2306, doi. 10.3892/or.2018.6305
    By:
    • Ferrari, Silvia Martina;
    • Bocci, Guido;
    • Di Desidero, Teresa;
    • Ruffilli, Ilaria;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Fioravanti, Anna;
    • Orlandi, Paola;
    • Paparo, Sabrina Rosaria;
    • Patrizio, Armando;
    • Piaggi, Simona;
    • Motta, Concettina La;
    • Ulisse, Salvatore;
    • Baldini, Enke;
    • Materazzi, Gabriele;
    • Miccoli, Paolo;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    39

    Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.

    Published in:
    Oncology Reports, 2018, v. 39, n. 5, p. 2225, doi. 10.3892/or.2018.6306
    By:
    • Ferrari, Silvia Martina;
    • Bocci, Guido;
    • Di Desidero, Teresa;
    • Elia, Giusy;
    • Ruffilli, Ilaria;
    • Ragusa, Francesca;
    • Orlandi, Paola;
    • Paparo, Sabrina Rosaria;
    • Patrizio, Armando;
    • Piaggi, Simona;
    • Motta, Concettina La;
    • Ulisse, Salvatore;
    • Baldini, Enke;
    • Materazzi, Gabriele;
    • Miccoli, Paolo;
    • Antonelli, Alessandro;
    • Fallahi, Poupak
    Publication type:
    Article
    40
    41

    CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In Vivo.

    Published in:
    2014
    By:
    • Antonelli, Alessandro;
    • Bocci, Guido;
    • Fallahi, Poupak;
    • La Motta, Concettina;
    • Ferrari, Silvia Martina;
    • Mancusi, Caterina;
    • Fioravanti, Anna;
    • Di Desidero, Teresa;
    • Sartini, Stefania;
    • Corti, Alessandro;
    • Piaggi, Simona;
    • Materazzi, Gabriele;
    • Spinelli, Claudio;
    • Fontanini, Gabriella;
    • Danesi, Romano;
    • Da Settimo, Federico;
    • Miccoli, Paolo
    Publication type:
    Journal Article
    42
    43
    44

    Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 2, p. E288, doi. 10.1210/jc.2010-1905
    By:
    • Antonelli, Alessandro;
    • Bocci, Guido;
    • La Motta, Concettina;
    • Ferrari, Silvia Martina;
    • Fallahi, Poupak;
    • Fioravanti, Anna;
    • Sartini, Stefania;
    • Minuto, Michele;
    • Piaggi, Simona;
    • Corti, Alessandro;
    • Alì, Greta;
    • Berti, Piero;
    • Fontanini, Gabriella;
    • Danesi, Romano;
    • Da Settimo, Federico;
    • Miccoli, Paolo
    Publication type:
    Article
    45
    46

    Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 1, p. 314, doi. 10.1210/jc.2009-0677
    By:
    • Antonelli, Alessandro;
    • Mosca, Marta;
    • Fallahi, Poupak;
    • Neri, Rossella;
    • Ferrari, Silvia Martina;
    • D'Ascanio, Anna;
    • Ghiri, Emiliano;
    • Carli, Linda;
    • Miccoli, Paolo;
    • Bombardieri, Stefano
    Publication type:
    Article
    47
    48

    Myo-inositol in autoimmune thyroiditis, and hypothyroidism.

    Published in:
    Reviews in Endocrine & Metabolic Disorders, 2018, v. 19, n. 4, p. 349, doi. 10.1007/s11154-018-9477-9
    By:
    • Fallahi, Poupak;
    • Ferrari, Silvia Martina;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Paparo, Sabrina Rosaria;
    • Caruso, Claudia;
    • Guglielmi, Giovanni;
    • Antonelli, Alessandro
    Publication type:
    Article
    49

    The protective effect of myo-inositol on human thyrocytes.

    Published in:
    Reviews in Endocrine & Metabolic Disorders, 2018, v. 19, n. 4, p. 355, doi. 10.1007/s11154-018-9476-x
    By:
    • Ferrari, Silvia Martina;
    • Elia, Giusy;
    • Ragusa, Francesca;
    • Paparo, Sabrina Rosaria;
    • Caruso, Claudia;
    • Benvenga, Salvatore;
    • Fallahi, Poupak;
    • Antonelli, Alessandro
    Publication type:
    Article
    50

    Thyroid disorders induced by checkpoint inhibitors.

    Published in:
    Reviews in Endocrine & Metabolic Disorders, 2018, v. 19, n. 4, p. 325, doi. 10.1007/s11154-018-9463-2
    By:
    • Ferrari, Silvia Martina;
    • Fallahi, Poupak;
    • Galetta, Fabio;
    • Citi, Emanuele;
    • Benvenga, Salvatore;
    • Antonelli, Alessandro
    Publication type:
    Article